Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,685 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In-silico evaluation of Bismurrayaquinone-A phytochemical as a potential multifunctional inhibitor targeting dihydrofolate reductase: implications for anticancer and antibacterial drug development.
Qian L, Khalid M, Alqarni MH, Alshmmari SK, Almoyad MAA, Wahab S, Alsayari A, Li SJ. Qian L, et al. Among authors: khalid m. J Biomol Struct Dyn. 2024 Jan 2:1-15. doi: 10.1080/07391102.2023.2299306. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38165437
Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Mat Rani NNI, Wu YS, Jeyabalan S. Velayutham NK, et al. Among authors: khalid m. Front Pharmacol. 2023 Mar 28;14:1150270. doi: 10.3389/fphar.2023.1150270. eCollection 2023. Front Pharmacol. 2023. PMID: 37056983 Free PMC article.
Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Izzati Mat Rani NN, Wu YS, Jeyabalan S. Velayutham NK, et al. Among authors: khalid m. Front Pharmacol. 2024 Jan 17;15:1343756. doi: 10.3389/fphar.2024.1343756. eCollection 2024. Front Pharmacol. 2024. PMID: 38299157 Free PMC article.
Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via in vitro and molecular docking approaches.
Rizvi SMD, Almazni IA, Moawadh MS, Alharbi ZM, Helmi N, Alqahtani LS, Hussain T, Alafnan A, Moin A, Elkhalifa AO, Awadelkareem AM, Khalid M, Tiwari RK. Rizvi SMD, et al. Among authors: khalid m. Front Chem. 2024 Feb 16;12:1352009. doi: 10.3389/fchem.2024.1352009. eCollection 2024. Front Chem. 2024. PMID: 38435669 Free PMC article.
1,685 results